SRPT logo

Sarepta Therapeutics (SRPT) Gross profit

Annual gross profit:

$1.58B+$489.89M(+44.82%)
December 31, 2024

Summary

  • As of today (June 22, 2025), SRPT annual gross profit is $1.58 billion, with the most recent change of +$489.89 million (+44.82%) on December 31, 2024.
  • During the last 3 years, SRPT annual gross profit has risen by +$978.04 million (+161.70%).
  • SRPT annual gross profit is now at all-time high.

Performance

SRPT Gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTincome statement metrics

quarterly gross profit:

$607.29M+$81.18M(+15.43%)
March 1, 2025

Summary

  • As of today (June 22, 2025), SRPT quarterly gross profit is $607.29 million, with the most recent change of +$81.18 million (+15.43%) on March 1, 2025.
  • Over the past year, SRPT quarterly gross profit has increased by +$244.39 million (+67.34%).
  • SRPT quarterly gross profit is now at all-time high.

Performance

SRPT quarterly gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTincome statement metrics

TTM gross profit:

$1.83B+$244.39M(+15.44%)
March 1, 2025

Summary

  • As of today (June 22, 2025), SRPT TTM gross profit is $1.83 billion, with the most recent change of +$244.39 million (+15.44%) on March 1, 2025.
  • Over the past year, SRPT TTM gross profit has increased by +$589.85 million (+47.67%).
  • SRPT TTM gross profit is now at all-time high.

Performance

SRPT TTM gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTincome statement metrics

Gross profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

SRPT Gross profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+44.8%+67.3%+47.7%
3 y3 years+161.7%+238.5%+177.0%
5 y5 years+388.2%+501.0%+421.6%

SRPT Gross profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+161.7%at high+238.5%at high+177.0%
5 y5-yearat high+388.2%at high+501.0%at high+421.6%
alltimeall timeat high>+9999.0%at high>+9999.0%at high>+9999.0%

SRPT Gross profit History

DateAnnualQuarterlyTTM
Mar 2025
-
$607.29M(+15.4%)
$1.83B(+15.4%)
Dec 2024
$1.58B(+44.8%)
$526.11M(+40.1%)
$1.58B(+12.3%)
Sep 2024
-
$375.48M(+17.9%)
$1.41B(+6.1%)
Jun 2024
-
$318.39M(-12.3%)
$1.33B(+7.4%)
Mar 2024
-
$362.90M(+2.9%)
$1.24B(+13.2%)
Dec 2023
$1.09B(+37.8%)
$352.61M(+19.6%)
$1.09B(+12.9%)
Sep 2023
-
$294.79M(+29.8%)
$968.02M(+12.1%)
Jun 2023
-
$227.11M(+4.0%)
$863.54M(+3.8%)
Mar 2023
-
$218.48M(-4.0%)
$832.12M(+4.9%)
Dec 2022
$793.02M(+31.1%)
$227.63M(+19.6%)
$793.02M(+7.9%)
Sep 2022
-
$190.32M(-2.7%)
$735.11M(+3.4%)
Jun 2022
-
$195.69M(+9.1%)
$710.76M(+7.7%)
Mar 2022
-
$179.39M(+5.7%)
$659.64M(+9.1%)
Dec 2021
$604.84M(+26.9%)
$169.72M(+2.3%)
$604.84M(+8.4%)
Sep 2021
-
$165.96M(+14.8%)
$557.86M(+7.1%)
Jun 2021
-
$144.57M(+16.0%)
$520.80M(+4.1%)
Mar 2021
-
$124.58M(+1.5%)
$500.25M(+4.9%)
Dec 2020
$476.72M(+47.0%)
$122.73M(-4.8%)
$476.72M(+8.7%)
Sep 2020
-
$128.91M(+3.9%)
$438.53M(+10.8%)
Jun 2020
-
$124.02M(+22.7%)
$395.62M(+12.9%)
Mar 2020
-
$101.05M(+19.5%)
$350.35M(+8.1%)
Dec 2019
$324.25M(+21.5%)
$84.55M(-1.7%)
$324.25M(+4.3%)
Sep 2019
-
$86.00M(+9.2%)
$310.98M(+5.5%)
Jun 2019
-
$78.75M(+5.1%)
$294.72M(+4.2%)
Mar 2019
-
$74.95M(+5.1%)
$282.77M(+6.0%)
Dec 2018
$266.84M(+81.2%)
$71.28M(+2.2%)
$266.84M(+7.0%)
Sep 2018
-
$69.75M(+4.4%)
$249.29M(+12.1%)
Jun 2018
-
$66.79M(+13.2%)
$222.42M(+17.0%)
Mar 2018
-
$59.02M(+9.8%)
$190.13M(+29.1%)
Dec 2017
$147.23M(+2667.5%)
$53.73M(+25.3%)
$147.23M(+49.0%)
Sep 2017
-
$42.88M(+24.3%)
$98.82M(+76.6%)
Jun 2017
-
$34.51M(+114.1%)
$55.94M(+160.9%)
Mar 2017
-
$16.12M(+203.0%)
$21.44M(+303.0%)
DateAnnualQuarterlyTTM
Dec 2016
$5.32M(+324.6%)
$5.32M(>+9900.0%)
$5.32M(>+9900.0%)
Sep 2016
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2016
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2016
-
$0.00(-100.0%)
$0.00(-100.0%)
Dec 2015
$1.25M(-87.2%)
-
-
Dec 2014
$9.76M(-44.5%)
-
-
Sep 2011
-
$7.52M(-35.1%)
$33.41M(-3.4%)
Jun 2011
-
$11.59M(-19.0%)
$34.58M(+28.1%)
Mar 2011
-
$14.30M(+64.3%)
$27.00M(+41.8%)
Sep 2010
-
$8.70M(+117.7%)
$19.04M(+14.1%)
Jun 2010
-
$4.00M(+231.7%)
$16.69M(+6.7%)
Mar 2010
-
$1.21M(-76.5%)
$15.64M(-11.1%)
Dec 2009
$17.59M(-17.3%)
$5.14M(-19.1%)
$17.59M(+41.3%)
Sep 2009
-
$6.35M(+115.7%)
$12.45M(+104.2%)
Jun 2009
-
$2.94M(-6.5%)
$6.09M(-25.1%)
Mar 2009
-
$3.15M(-36.8%)
$8.13M(-23.3%)
Dec 2008
$21.26M(+1140.4%)
-
-
Jun 2008
-
$4.98M(-11.4%)
$10.61M(+88.6%)
Mar 2008
-
$5.63M(+2626.6%)
$5.63M(+228.2%)
Dec 2000
$1.71M(+328.4%)
$206.30K(-1.1%)
$1.71M(+0.4%)
Sep 2000
-
$208.70K(+121.5%)
$1.71M(+6.8%)
Jun 2000
-
$94.20K(-92.2%)
$1.60M(+6.3%)
Mar 2000
-
$1.20M(+502.3%)
$1.50M(+200.9%)
Dec 1999
$400.00K(+33.3%)
$200.00K(+100.0%)
$500.00K(+66.7%)
Sep 1999
-
$100.00K(-50.0%)
$300.00K(-50.0%)
Mar 1999
-
$200.00K(>+9900.0%)
$600.00K(0.0%)
Dec 1998
$300.00K(-50.0%)
$0.00(-100.0%)
$600.00K(-25.0%)
Sep 1998
-
$200.00K(0.0%)
$800.00K(+33.3%)
Jun 1998
-
$200.00K(0.0%)
$600.00K(-14.3%)
Mar 1998
-
$200.00K(0.0%)
$700.00K(0.0%)
Dec 1997
$600.00K(0.0%)
$200.00K(-33.3%)
$700.00K(+40.0%)
Jun 1997
-
$300.00K(+50.0%)
$500.00K(+150.0%)
Mar 1997
-
$200.00K
$200.00K
Dec 1996
$600.00K
-
-

FAQ

  • What is Sarepta Therapeutics annual gross profit?
  • What is the all time high annual gross profit for Sarepta Therapeutics?
  • What is Sarepta Therapeutics annual gross profit year-on-year change?
  • What is Sarepta Therapeutics quarterly gross profit?
  • What is the all time high quarterly gross profit for Sarepta Therapeutics?
  • What is Sarepta Therapeutics quarterly gross profit year-on-year change?
  • What is Sarepta Therapeutics TTM gross profit?
  • What is the all time high TTM gross profit for Sarepta Therapeutics?
  • What is Sarepta Therapeutics TTM gross profit year-on-year change?

What is Sarepta Therapeutics annual gross profit?

The current annual gross profit of SRPT is $1.58B

What is the all time high annual gross profit for Sarepta Therapeutics?

Sarepta Therapeutics all-time high annual gross profit is $1.58B

What is Sarepta Therapeutics annual gross profit year-on-year change?

Over the past year, SRPT annual gross profit has changed by +$489.89M (+44.82%)

What is Sarepta Therapeutics quarterly gross profit?

The current quarterly gross profit of SRPT is $607.29M

What is the all time high quarterly gross profit for Sarepta Therapeutics?

Sarepta Therapeutics all-time high quarterly gross profit is $607.29M

What is Sarepta Therapeutics quarterly gross profit year-on-year change?

Over the past year, SRPT quarterly gross profit has changed by +$244.39M (+67.34%)

What is Sarepta Therapeutics TTM gross profit?

The current TTM gross profit of SRPT is $1.83B

What is the all time high TTM gross profit for Sarepta Therapeutics?

Sarepta Therapeutics all-time high TTM gross profit is $1.83B

What is Sarepta Therapeutics TTM gross profit year-on-year change?

Over the past year, SRPT TTM gross profit has changed by +$589.85M (+47.67%)
On this page